Blog Page 75

On thin ice: how the quest for a billion-dollar microbe is running out of control in Earth’s last wilderness
A new UN study implies that searching for exremeophiles in areas such as the Antarctic “is threatening to plunder the planet’s last wilderness.” The body of the report, however, seems to focus on intellectual property issues.

While are cases where pharmaceutical companies have patented indigenous products (eg. neem), there are no Antarctic natives! The aim of the report seems to be to establish guidelines to level the playing field, because “ethical companies felt they could not assert their intellectual property rights with government agencies.”

I’m not sure I really understand what any of this has to do with plundering the wilderness. Seems more like the sort of crisis-by-equivocation that the United Nations is famous for.

Management issues challenge biotech startups
This article reviews a very interesting report that basically faults the failure of biotechnology companies to successfuly transition from research focus to product development and commercialization on hiring managers with a scientific rather than managerial forte and aiming to pass regulatory hurdles rather than build a company.
Industry observations certainly support this thesis. It’s nice to see that the effort has been made to examine and document it.